XINHUA CHEMICAL(603867)
Search documents
新化股份(603867) - 2020 Q1 - 季度财报
2020-04-29 16:00
Financial Performance - Operating income fell by 35.10% to CNY 352,579,131.13, down from CNY 543,290,219.75 in the same period last year[5] - Net profit attributable to shareholders decreased by 49.78% to CNY 20,399,880.12, compared to CNY 40,621,707.54 in the previous year[5] - Basic and diluted earnings per share decreased by 61.54% to CNY 0.15 per share[5] - Operating profit fell to CNY 22.79 million, down 60.11% from CNY 57.13 million year-on-year[12] - Net profit decreased by 58.89% to CNY 19.51 million, compared to CNY 47.45 million in the previous year[13] - The company reported a total profit of CNY 29,989,725.08, a decrease of 13.5% from CNY 34,611,079.81 in Q1 2019[28] Cash Flow - Cash flow from operating activities showed a significant decline of 242.81%, resulting in a net cash outflow of CNY 35,068,302.86[5] - Cash flow from operating activities showed a net outflow of CNY 35.07 million, a decline of 242.81% from a net inflow of CNY 24.56 million in the same period last year[13] - The company reported a cash inflow from operating activities of ¥266,442,677.98 in Q1 2020, down 36.9% from ¥422,185,359.24 in Q1 2019[30] - Net cash flow from operating activities was -CNY 43,192,905.88 in Q1 2020, compared to -CNY 36,389,222.42 in Q1 2019, indicating a worsening performance year-over-year[33] - The company reported a net cash decrease of CNY 58,892,013.13 in Q1 2020, compared to a decrease of CNY 62,231,940.64 in Q1 2019, indicating a slight improvement in cash management[34] Assets and Liabilities - Total assets decreased by 1.13% to CNY 2,170,599,801.91 compared to the end of the previous year[5] - Accounts receivable increased by 45.38% to CNY 167,507,914.36 due to reduced sales collections impacted by the pandemic[11] - Other non-current assets rose by 52.62% to CNY 28,549,331.81, primarily due to increased prepayments for equipment purchases[11] - Total liabilities reached CNY 774,083,008.43, with current liabilities at CNY 693,672,558.79 and non-current liabilities at CNY 80,410,449.64[37] - The company’s total liabilities to total assets ratio stands at approximately 35.3%[37] Shareholder Information - The number of shareholders reached 14,054, with the largest shareholder holding 17.22% of the shares[9] - Total equity reached approximately 1.28 billion, indicating strong financial health[41] - Unallocated profits amounted to approximately 556.8 million, reflecting retained earnings[41] Government Support and Subsidies - The company received government subsidies amounting to CNY 2,810,591.99, which are closely related to its normal business operations[8] Taxation - Tax expenses decreased by 74.76% to CNY 2.40 million, primarily due to the recognition of deferred tax assets[13] - The company experienced a 250.79% increase in payable taxes, rising to CNY 5.96 million, attributed to reduced deductions for fixed asset investments[12] - The company reported a tax expense of ¥3,739,538.44 for Q1 2020, down from ¥4,414,715.51 in Q1 2019, reflecting a decrease of 15.3%[28] Investment and Expenses - The company reported a significant reduction in financial expenses, down 87.08% to CNY 764,229 from CNY 5.91 million year-on-year[12] - Research and development expenses for Q1 2020 were ¥7,527,218.81, a decrease of 26.5% compared to ¥10,237,389.70 in Q1 2019[28] - The company experienced a decrease in sales expenses, which were ¥10,576,740.76 in Q1 2020, down from ¥13,729,266.93 in Q1 2019, indicating a reduction of 22.5%[28]
新化股份(603867) - 2019 Q4 - 年度财报
2020-04-22 16:00
Financial Performance - The company's operating revenue for 2019 was ¥1,717,987,561.37, a decrease of 23.04% compared to ¥2,232,215,716.86 in 2018[21] - The net profit attributable to shareholders for 2019 was ¥123,495,088.09, down 29.24% from ¥174,536,081.28 in 2018[21] - The net profit after deducting non-recurring gains and losses was ¥111,813,173.99, a decrease of 30.46% compared to ¥160,790,346.98 in 2018[21] - Basic earnings per share decreased by 39.16% to CNY 1.01 compared to CNY 1.66 in the previous year[23] - Net profit attributable to shareholders decreased by 29.24% year-on-year, while net profit excluding non-recurring gains and losses fell by 30.46%[24] - The weighted average return on equity decreased by 13.11 percentage points to 11.48% from 24.59% in the previous year[23] - The gross profit margin increased to 23.54%, up from 21.66% year-on-year[52] - The operating costs decreased by 24.88% to 1,313,604,274.24 CNY, reflecting the impact of production halts[52] - The company achieved a significant reduction in financial expenses by 49.52%, amounting to CNY 8,244,065.90[65] Cash Flow and Assets - The cash flow from operating activities for 2019 was ¥235,645,271.30, an increase of 14.53% from ¥205,758,634.31 in 2018[21] - The total assets at the end of 2019 were ¥2,195,478,165.97, representing a 27.30% increase from ¥1,724,618,109.01 at the end of 2018[21] - The net assets attributable to shareholders increased by 70.03% to ¥1,343,368,224.52 from ¥790,089,651.01 in 2018[21] - The company reported a significant decrease in cash received from sales, leading to a reduction in sales revenue[68] - Cash received from investment activities increased to ¥125.7 million, marking a 100% increase compared to the previous period[68] - The company’s fixed asset and intangible asset purchases rose by 50.16% to ¥76.26 million[68] - Accounts receivable decreased by 37.93% to ¥115.22 million, attributed to a decline in operating income[71] Production and Operations - The company focuses on the production of fatty amines, organic solvents, and fine chemical products, emphasizing innovation and environmental sustainability[32] - The company operates under a production model that aligns production with sales plans, ensuring timely delivery to customers through multi-department collaboration[35] - The production of key products like fatty amines and organic solvents saw a decline in sales volume, with fatty amines sales down by 0.19%[58] - The company experienced a significant impact on production due to the March 21 explosion in Jiangsu, leading to a halt in production for several subsidiaries[93] - The company is gradually restoring production at Jiangsu Xinrui following the "3.21 explosion" incident, with partial resumption of operations[48] Research and Development - The total R&D expenditure for the period was CNY 58,361,186.54, accounting for 3.40% of total revenue[66] - The company has established a strong R&D platform, recognized as a national key high-tech enterprise, and has undertaken multiple national and provincial technology projects[85] - The company has applied for 8 invention patents and 5 utility model patents in 2019, with 3 invention patents and 10 utility model patents granted by the end of the year, totaling 35 invention patents and 20 utility model patents[86] Market Position and Strategy - The company has a strong market position in the fatty amine sector, with a large production capacity and long-term partnerships with major agricultural chemical companies[41] - The company aims for high-quality development and strategic expansion, particularly in its Ningxia development base, to enhance performance in the face of new market conditions[46] - The company aims to enhance its core business in fatty amines, organic solvents, and flavors, focusing on low-cost and technological innovation to maintain market leadership[108] Environmental and Social Responsibility - The company has implemented environmental protection measures, complying with pollution discharge standards[182] - The company has committed to social responsibility, contributing to local economic development and being recognized as a top taxpayer in Jiande City[180] - The company actively participates in charitable activities, including donations and community building initiatives[181] - The company has established a comprehensive solid waste management system, ensuring hazardous waste is disposed of by qualified units and general solid waste is utilized appropriately[187] Shareholder Commitments and Governance - Major shareholders holding over 5% of the company's shares have committed to not transferring or managing their shares for 36 months post-IPO[124] - Shareholders have agreed to limit their annual share transfers to no more than 25% of their total holdings during their tenure as directors or senior management[126] - The company commits to minimizing related party transactions to protect the interests of all shareholders[132] - The company will compensate investors for losses caused by false statements or omissions in the IPO prospectus according to relevant laws[135] Compliance and Risk Management - The company has no major litigation or arbitration matters during the reporting period[166] - The company has no significant accounting errors to correct for the reporting period[162] - The company faces risks related to environmental policies and safety, which may require increased investment in environmental protection facilities, potentially impacting profitability[111] - The company is exposed to raw material price volatility risks, as the cost of basic chemical raw materials is closely linked to oil prices and market supply-demand dynamics[112]
新化股份(603867) - 2019 Q3 - 季度财报
2019-10-28 16:00
2019 年第三季度报告 公司代码:603867 公司简称:新化股份 浙江新化化工股份有限公司 2019 年第三季度报告 1 / 27 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 5 | | 四、 | 附录 | 8 | 2019 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人胡健、主管会计工作负责人洪益琴及会计机构负责人(会计主管人员)洪益琴保 证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 3 / 27 单位:元 币种:人民币 本报告期末 上年度末 本报告期末比上年 度末增减(%) 总资产 2,087,070,213.50 1,724,618,109.01 21.02 归属于上市公司股东的净资产 1, ...
新化股份(603867) - 2019 Q2 - 季度财报
2019-09-09 16:00
2019 年半年度报告 公司代码:603867 公司简称:新化股份 浙江新化化工股份有限公司 2019 年半年度报告 1 / 172 2019 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、 准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法 律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人胡健、主管会计工作负责人洪益琴及会计机构负责人(会计主管人员) 洪益琴声明:保证半年度报告中财务报告的真实、准确、完整。 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 经公司财务部门核算, 2019 年 1-6 月公司实现归属母公司股东的净利润为 8,370.15 万元。报告期末,合并报表未分配利润余额为 61,653.50 万元,母公司可供 分配利润 55,424.59 万元。 为兼顾股东利益和公司发展的需要,拟定 2019 年半年度利润分配方案如下: 公司拟以股权登记日的总股本为基数,向全体股东每 10 股派发现金股利 2.50 元 (含税),预计派发现金 35,000,000.00 元 ...
新化股份(603867) - 2019 Q2 - 季度财报
2019-08-22 16:00
2019 年半年度报告 公司代码:603867 公司简称:新化股份 浙江新化化工股份有限公司 2019 年半年度报告 1 / 172 2019 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、 准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法 律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人胡健、主管会计工作负责人洪益琴及会计机构负责人(会计主管人员) 洪益琴声明:保证半年度报告中财务报告的真实、准确、完整。 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 经公司财务部门核算, 2019 年 1-6 月公司实现归属母公司股东的净利润为 8,370.15 万元。报告期末,合并报表未分配利润余额为 61,653.50 万元,母公司可供 分配利润 55,424.59 万元。 为兼顾股东利益和公司发展的需要,拟定 2019 年半年度利润分配方案如下: 公司拟以股权登记日的总股本为基数,向全体股东每 10 股派发现金股利 2.50 元 (含税),预计派发现金 35,000,000.00 元 ...